Skip to main content

Dr Reddys Labs receives EIR from USFDA for Srikakulam based facility

Dr Reddys Labs has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the formulations manufacturing facility in Srikakulam, Andhra Pradesh.

USFDA had conducted an inspection on 7th July 2022 at formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.

Bayer launches its blockbuster drug finerenone in India

Bayer launches its blockbuster drug finerenone to treat chronic kidney disease (CKD) associated with type-II diabetes in India.This drug will be available as brand name of Kerendia in India.

India is becoming the hub of diabetes and CKD is common in people with diabetes. Approximately 1 in 3 adults with diabetes has CKD. Both type 1 and type 2 diabetes can cause kidney disease. where, finerenone is used to treat CKD associated with type-II diabetes.

Opportunity for M.Pharm or M.Sc to Join NISG as National Consultant | Salary Rs.1,52,400

National Institute for Smart Government (NISG) is a not-for-profit company set up in 2002 by the Government of India (GoI) on the Public-Private-Partnership (PPP) model with Secretary, Ministry of Electronics and Information Technology (MeitY) as its Chairman. NISG is shaped as an institution of excellence in e-governance to assist governments for ushering in smart governance, process reforms and digitalization.

Direct Recruitment for Pharmacists (07 posts) at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Career for Pharmacists (10 posts) under Central government Health Scheme

For the last six decades Central Government Health Scheme is providing comprehensive medical care to the Central Government employees and pensioners enrolled under the scheme. In fact CGHS caters to the healthcare needs of eligible beneficiaries covering all four pillars of democratic set up in India namely Legislature, Judiciary, Executive and Press.

Job for Pharmacy Graduates as Consultant at NISG - Salary Rs. 99,060 pm

National Institute for Smart Government (NISG) is a not-for-profit company set up in 2002 by the Government of India (GoI) on the Public-Private-Partnership (PPP) model with Secretary, Ministry of Electronics and Information Technology (MeitY) as its Chairman. NISG is shaped as an institution of excellence in e-governance to assist governments for ushering in smart governance, process reforms and digitalization.

Job for Pharmacist under National Tuberculosis Eradication Program

District Welfare Society Selection Committee, Nilgiri District invites applications from eligible candidates for the following vacancies under the National Tuberculosis Eradication Program on contract basis for 11 months.  All these jobs are purely temporary.

Post : Pharmacist

M.Sc Microbiology or Pharmacy Job at Postgraduate Institute of Medical Education & Research

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Walk in interview for M.Pharm, M.Sc, B.Pharm in Quality Assurance Department at MSN Laboratories Pvt Ltd

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Quality Assurance Dept. - Formulation Division

Vacancy for Senior Research Associate / Associate Scientist at Aragen Life Sciences

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.

Novartis to separate Sandoz as a standalone company

Novartis announced its intention to separate Sandoz, its generics and biosimilars division into a new publicly traded standalone company, by way of a 100% spin-off.

The spin-off aims to maximize shareholder value by creating the #1 European generics company1 and a global leader in biosimilars, allowing Novartis shareholders to participate fully in the potential future upside for both Sandoz and Novartis Innovative Medicines.

Lupin and Irom Enter into an Exclusive Licensing Agreement for Denosumab biosimilar for Japan

Lupin Limited announced that it has entered into an exclusive licensing agreement with I'rom Group Co. Ltd (Irom), a leading pharmaceutical company in Japan. Under the terms of the Agreement, Irom will conduct clinical trials along with Lupin, register, distribute and market biosimilar Denosumab in Japan on an exclusive basis.

Technology Developed at UH Could Advance Treatment of Lymphoma

In the war against cancer, one of the most critical battles is waged on a cellular level as T cells from the immune system are altered in the lab to attack cancer cells. This form of immunotherapy, called chimeric antigen receptor (CAR) T-cell therapy, can be a life-saving treatment resulting in tumor control lasting ten years or longer. 

Trinity team’s new gene therapy shows promise for treating eye condition affecting millions across the globe

Researchers from Trinity College Dublin have developed a new gene therapy approach that shows promise for treating the dry form of Age Related Macular Degeneration (AMD) – a progressive eye disease that affects up to 10% of adults over 65 years of age and is a leading cause of severe vision impairment and blindness in this age group.

Already approved drug could pave way to new pharmaceuticals

Many tumor cells mist themselves with a protective perfume that disables the immune system. But a drug already approved for other purposes can apparently render this weapon harmless. This is shown in a study by the University of Bonn and the University Medical Center Hamburg-Eppendorf, which has now appeared in the Journal for ImmunoTherapy of Cancer. The researchers now want to further optimize the compound. In the medium term, this could pave the way for new anti-cancer drugs.

Pharmazz India gets CDSCO panel nod for Sovateltide injection

The Subject expert committee, SEC of CDSCO recommended grant of permission for manufacturing and marketing and permission to conduct the Phase IV Clinical trial of Sovateltide injection by Pharmazz India.

Pharmazz India has submitted an application to receive permission for manufacturing, marketing and conduct phase IV trial in the country. Earlier SEC meeting held on 28.06.2022, the firm presented a proposal for permission for manufacturing and marketing along with Phase IV Clinical trial protocol before the committee.

TN Association requesting PCI, not to take exit examination

Tamil Nadu All Registered Pharmacists Welfare Association requesting Pharmacy council of India to not conduct the exit examination for Pharmacists.

The General Secretary, of TNARPW association said that, we have received notification about exit exam for pharmacy students for upcoming November 2022. We are not happy by this announcement actually. Our association clearly stands with welfare of public at all the time. But we are expecting some response from PCI for our questions.

NPPA rejects Intas Pharma application for exemption of Clozapine from DPCO

National Pharmaceutical Pricing Authority, NPPA has rejected the application of Intas Pharmaceuticals for exemption from the provisions of Drug Price Control Order, DPCO, 2013 under Para 32 (iii) for the formulations Clozapine Extended Release Capsules.

The expert committee of NPPA had received application from Intas Pharmaceuticals for exemption from the provisions of DPCO 2013 under para 32 (iii) for the formulations Clozapine extended release capsules 12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg.

Glenmark Pharma gets OAI for US based plant

Glenmark Pharma Monroe, North Carolina (USA) based Facility has received a communication from the US FDA indicating the inspection classification as Official Action Indicated (OAI).

The OAI classification implies interalia that the US FDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved.

M.Pharm or M.Sc Job as Senior Research Fellow at NIANP

The National Institute of Animal Nutrition and Physiology (NIANP) was established on 24th November 1995 at Bangalore under the aegis of Indian Council of Agricultural Research (ICAR), New Delhi. The Institute is mandated to conduct basic and fundamental research with respect to animal feed resource management using physiological-nutritional approaches to improve animal productivity and profitability of livestock farmers.

Post : Senior Research Fellow (SRF) (One position)

Subscribe to